W. Fraser Symmans

W. Fraser Symmans

UNVERIFIED PROFILE

Are you W. Fraser Symmans?   Register this Author

Register author
W. Fraser Symmans

W. Fraser Symmans

Publications by authors named "W. Fraser Symmans"

Are you W. Fraser Symmans?   Register this Author

100Publications

2776Reads

32Profile Views

Imaging features of triple-negative breast cancers according to androgen receptor status.

Eur J Radiol 2019 May 21;114:167-174. Epub 2019 Mar 21.

Department of Diagnostic Radiology, Unit 1350, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, TX, 77030, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejrad.2019.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6481318PMC
May 2019

Accurate RNA Sequencing From Formalin-Fixed Cancer Tissue To Represent High-Quality Transcriptome From Frozen Tissue.

JCO Precis Oncol 2018 26;2018. Epub 2018 Jan 26.

Departments of Pathology and Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5976456PMC
http://dx.doi.org/10.1200/PO.17.00091DOI Listing
January 2018

Long-Term Prognostic Risk After Neoadjuvant Chemotherapy Associated With Residual Cancer Burden and Breast Cancer Subtype.

J Clin Oncol 2017 Apr 30;35(10):1049-1060. Epub 2017 Jan 30.

W. Fraser Symmans, Caimiao Wei, Rebekah Gould, Xian Yu, Ya Zhang, Maheshwari Ramineni, Kelly Hunt, Thomas A. Buchholz, Vicente Valero, Aman U. Buzdar, Wei Yang, Abenaa M. Brewster, Stacy Moulder, and Gabriel N. Hortobagyi, University of Texas MD Anderson Cancer Center, Houston; Andrew Walls, Uniformed Services University of the Health Sciences, San Antonio, TX; Mei Liu, The General Hospital of People's Liberation Army, Beijing, China; Alex Bousamra, Allegheny General Hospital, Pittsburgh, PA; Bruno Sinn, Charite-Universitatsmedizin, Berlin, Germany; and Lajos Pusztai and Christos Hatzis, Yale University School of Medicine, New Haven, CT.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2015.63.1010DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5455352PMC
April 2017

Standardizing of Pathology in Patients Receiving Neoadjuvant Chemotherapy.

Ann Surg Oncol 2016 10 5;23(10):3153-61. Epub 2016 Jul 5.

The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-016-5317-xDOI Listing
October 2016

Adaptive Randomization of Neratinib in Early Breast Cancer.

N Engl J Med 2016 Jul;375(1):11-22

From University of California, San Francisco (J.W.P., C.Y., L.J.V., N.M.H., M.B.B., A.J.C., M.M., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California, San Diego, San Diego (A.M.W., R.S., T.H.), and University of Southern California, Los Angeles (D.T.) - all in California; Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Minnesota, Minneapolis (D.Y., T.C.H.), and Mayo Clinic, Rochester (J.C.B.) - both in Minnesota; M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), University of Texas Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; Gemini Group, Ann Arbor, MI (J.P.); University of Pennsylvania, Philadelphia (A.D.); Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); Swedish Medical Center, Seattle (H.G.K.); University of Chicago (R.N.) and Loyola University (K.S.A.) - both in Chicago; Inova Fairfax Hospital, Falls Church, VA (K.K.E.); University of Denver, Denver (A.D.E.); Mayo Clinic, Scottsdale (D.W.N.), and University of Arizona, Tucson (J.E.L., R.K.V.) - both in Arizona; University of Kansas, Lawrence (Q.J.K.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513750DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259558PMC
July 2016

Adaptive Randomization of Veliparib-Carboplatin Treatment in Breast Cancer.

N Engl J Med 2016 Jul;375(1):23-34

From University of California, San Francisco (UCSF) (H.S.R., C.Y., L.J.V., M.B.B., N.M.H., A.J.C., C.E., J.L., S.E.D., G.L.H., L.J.E.), and QuantumLeap Healthcare Collaborative (M.P.), San Francisco, Buck Institute for Research and Aging, Novato (C.Y.), University of California, Davis, Davis (M.H.), University of California San Diego, San Diego (A.M.W., R.S.), and University of Southern California, Los Angeles (D.T.) - all in California; University of Chicago (O.I.O., R.N.), and Loyola University (K.S.A.), Chicago; University of Pennsylvania, Philadelphia (A.D.); Gemini Group, Ann Arbor, MI (J.P.); University of Texas M.D. Anderson Cancer Center, Houston (W.F.S., L.P., S.L.M., D.A.B.), UT Southwestern Medical Center, Dallas (D.M.E., B.B.H.), and Berry Consultants, Austin (A.S., D.A.B.) - all in Texas; University of Minnesota, Minneapolis (D.Y.), and Mayo Clinic, Rochester (J.C.B., T.C.H.) - both in Minnesota; Swedish Medical Center, Seattle (H.G.K.); Georgetown Lombardi Comprehensive Cancer Center, Washington, DC (M.C.L., C.I.); University of Kansas, Lawrence (Q.J.K.); University of Arizona, Tucson (J.E.L., R.K.V.), and Mayo Clinic, Scottsdale (D.W.N.) - both in Arizona; Oregon Health and Sciences University, Portland (S.Y.C., K.A.K.); University of Denver, Denver (A.D.E.); Inova Fairfax Hospital, Falls Church, VA (K.K.E.); and Emory University, Atlanta (W.C.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1513749DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5259561PMC
July 2016

CCR 20th Anniversary Commentary: Divide and Conquer-Breast Cancer Subtypes and Response to Therapy.

Clin Cancer Res 2015 Aug;21(16):3575-7

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.

View Article

Download full-text PDF

Source
http://clincancerres.aacrjournals.org/cgi/doi/10.1158/1078-0
Publisher Site
http://dx.doi.org/10.1158/1078-0432.CCR-14-3121DOI Listing
August 2015

Translational research in the National Cancer Institute's cooperative groups.

Authors:
W Fraser Symmans

Clin Adv Hematol Oncol 2014 Nov;12(11):785-7

University of Texas MD Anderson Cancer Center, Houston, TX.

View Article

Download full-text PDF

Source
November 2014

Global gene expression changes induced by prolonged cold ischemic stress and preservation method of breast cancer tissue.

Mol Oncol 2014 May 17;8(3):717-27. Epub 2014 Feb 17.

Section of Medical Oncology, Yale Cancer Center, Yale School of Medicine, 333 Cedar Street, New Haven, CT 06520, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.molonc.2014.02.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4048748PMC
May 2014

Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers.

Breast Cancer Res Treat 2014 Apr 12;144(3):561-8. Epub 2014 Mar 12.

Yale Cancer Center, Yale School of Medicine, Yale University, 333 Cedar St, PO Box 208032, New Haven, CT, 06520, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-014-2904-zDOI Listing
April 2014

Breast cancer genomics: challenges in interpretation and application.

Oncologist 2013 ;18(4):e11-2

Department of Medical Oncology, Mater Misericordiae University Hospital, Dublin, Ireland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2013-0116DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639537PMC
December 2013

An international Ki67 reproducibility study.

J Natl Cancer Inst 2013 Dec 7;105(24):1897-906. Epub 2013 Nov 7.

Affiliations of authors: Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, MD (MCP, LMM); Pathology and Laboratory Medicine, University of British Columbia, Vancouver, British Columbia, Canada (SCYL, DG, EM, TON); Department of Laboratory Medicine and Pathology, University of Alberta, Alberta, Canada (JCH); Division of Pathology and Laboratory Medicine, European Institute of Oncology, Milan, Italy (MGM); Division of Pathology and Laboratory Medicine, European Institute of Oncology, and University of Milan, Milan, Italy (GV); Breakthrough Breast Cancer Research Centre, The Institute of Cancer Research, London, United Kingdom (LAZ); Department of Pathology, Centre Jean Perrin, Clermont-Ferrand, and Université d'Auvergne, France (FP-L); Transformative Pathology, Ontario Institute for Cancer Research, Toronto, Ontario, Canada (JMSB); PhenoPath Laboratories, Seattle, WA (AMG); Department of Pathology, MD Anderson Cancer Center, Houston, TX (WFS); Edinburgh Cancer Research Centre, Western General Hospital, Edinburgh, United Kingdom (TP); The EMMES Corporation, Rockville, MD (RAE); Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor, MI (DFH); Academic Department of Biochemistry, Royal Marsden Hospital, London, United Kingdom (MD); on behalf of the International Ki67 in Breast Cancer Working Group of the Breast International Group and North American Breast Cancer Group.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djt306DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888090PMC
December 2013

Differential response to neoadjuvant chemotherapy among 7 triple-negative breast cancer molecular subtypes.

Clin Cancer Res 2013 Oct 15;19(19):5533-40. Epub 2013 Aug 15.

Authors' Affiliations: Morgan Welch Inflammatory Breast Cancer Research Program and Clinic; Departments of Breast Medical Oncology, Bioinformatics and Computational Biology, Pathology, and Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas; and Department of Biochemistry, Vanderbilt-Ingram Cancer Center, Vanderbilt University School of Medicine, Nashville, Tennessee.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-13-0799DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813597PMC
October 2013

HER2 testing in patients with breast cancer.

BMJ 2012 Jun 11;344:e3958. Epub 2012 Jun 11.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/bmj.e3958DOI Listing
June 2012

A perspective on genomic tests for breast cancer: the need for progress.

Authors:
W Fraser Symmans

Oncology (Williston Park) 2012 Apr;26(4):364-5, 369

Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.

View Article

Download full-text PDF

Source
April 2012

Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancer.

Clin Cancer Res 2012 Feb 10;18(4):1109-19. Epub 2012 Jan 10.

Departments of Breast Medical Oncology, Systems Biology, Biostatistics, Surgical Oncology, and Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2762DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288822PMC
February 2012

Maximum predictive power of the microarray-based models for clinical outcomes is limited by correlation between endpoint and gene expression profile.

BMC Genomics 2011 Dec 23;12 Suppl 5:S3. Epub 2011 Dec 23.

The Center for Bioinformatics and The institute of Biomedical Sciences, School of Life Sciences, East China Normal University, Shanghai, 200241, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-12-S5-S3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287499PMC
December 2011

Maximizing biomarker discovery by minimizing gene signatures.

BMC Genomics 2011 Dec 23;12 Suppl 5:S6. Epub 2011 Dec 23.

The Center for Bioinformatics and Institute of Biomedical Sciences, School of Life Science, East China Normal University, 500 Dongchuan Road, Shanghai 200241, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2164-12-S5-S6DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3287502PMC
December 2011

First generation prognostic gene signatures for breast cancer predict both survival and chemotherapy sensitivity and identify overlapping patient populations.

Breast Cancer Res Treat 2011 Nov 11;130(1):155-64. Epub 2011 Aug 11.

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-011-1706-9DOI Listing
November 2011

Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.

Cancer 2010 Nov;116(21):4933-43

Department of Pathology, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1002/cncr.25443
Publisher Site
http://dx.doi.org/10.1002/cncr.25443DOI Listing
November 2010

Molecular anatomy of breast cancer stroma and its prognostic value in estrogen receptor-positive and -negative cancers.

J Clin Oncol 2010 Oct 30;28(28):4316-23. Epub 2010 Aug 30.

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston,TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.27.2419DOI Listing
October 2010

The MicroArray Quality Control (MAQC)-II study of common practices for the development and validation of microarray-based predictive models.

Authors:
Leming Shi Gregory Campbell Wendell D Jones Fabien Campagne Zhining Wen Stephen J Walker Zhenqiang Su Tzu-Ming Chu Federico M Goodsaid Lajos Pusztai John D Shaughnessy André Oberthuer Russell S Thomas Richard S Paules Mark Fielden Bart Barlogie Weijie Chen Pan Du Matthias Fischer Cesare Furlanello Brandon D Gallas Xijin Ge Dalila B Megherbi W Fraser Symmans May D Wang John Zhang Hans Bitter Benedikt Brors Pierre R Bushel Max Bylesjo Minjun Chen Jie Cheng Jing Cheng Jeff Chou Timothy S Davison Mauro Delorenzi Youping Deng Viswanath Devanarayan David J Dix Joaquin Dopazo Kevin C Dorff Fathi Elloumi Jianqing Fan Shicai Fan Xiaohui Fan Hong Fang Nina Gonzaludo Kenneth R Hess Huixiao Hong Jun Huan Rafael A Irizarry Richard Judson Dilafruz Juraeva Samir Lababidi Christophe G Lambert Li Li Yanen Li Zhen Li Simon M Lin Guozhen Liu Edward K Lobenhofer Jun Luo Wen Luo Matthew N McCall Yuri Nikolsky Gene A Pennello Roger G Perkins Reena Philip Vlad Popovici Nathan D Price Feng Qian Andreas Scherer Tieliu Shi Weiwei Shi Jaeyun Sung Danielle Thierry-Mieg Jean Thierry-Mieg Venkata Thodima Johan Trygg Lakshmi Vishnuvajjala Sue Jane Wang Jianping Wu Yichao Wu Qian Xie Waleed A Yousef Liang Zhang Xuegong Zhang Sheng Zhong Yiming Zhou Sheng Zhu Dhivya Arasappan Wenjun Bao Anne Bergstrom Lucas Frank Berthold Richard J Brennan Andreas Buness Jennifer G Catalano Chang Chang Rong Chen Yiyu Cheng Jian Cui Wendy Czika Francesca Demichelis Xutao Deng Damir Dosymbekov Roland Eils Yang Feng Jennifer Fostel Stephanie Fulmer-Smentek James C Fuscoe Laurent Gatto Weigong Ge Darlene R Goldstein Li Guo Donald N Halbert Jing Han Stephen C Harris Christos Hatzis Damir Herman Jianping Huang Roderick V Jensen Rui Jiang Charles D Johnson Giuseppe Jurman Yvonne Kahlert Sadik A Khuder Matthias Kohl Jianying Li Li Li Menglong Li Quan-Zhen Li Shao Li Zhiguang Li Jie Liu Ying Liu Zhichao Liu Lu Meng Manuel Madera Francisco Martinez-Murillo Ignacio Medina Joseph Meehan Kelci Miclaus Richard A Moffitt David Montaner Piali Mukherjee George J Mulligan Padraic Neville Tatiana Nikolskaya Baitang Ning Grier P Page Joel Parker R Mitchell Parry Xuejun Peng Ron L Peterson John H Phan Brian Quanz Yi Ren Samantha Riccadonna Alan H Roter Frank W Samuelson Martin M Schumacher Joseph D Shambaugh Qiang Shi Richard Shippy Shengzhu Si Aaron Smalter Christos Sotiriou Mat Soukup Frank Staedtler Guido Steiner Todd H Stokes Qinglan Sun Pei-Yi Tan Rong Tang Zivana Tezak Brett Thorn Marina Tsyganova Yaron Turpaz Silvia C Vega Roberto Visintainer Juergen von Frese Charles Wang Eric Wang Junwei Wang Wei Wang Frank Westermann James C Willey Matthew Woods Shujian Wu Nianqing Xiao Joshua Xu Lei Xu Lun Yang Xiao Zeng Jialu Zhang Li Zhang Min Zhang Chen Zhao Raj K Puri Uwe Scherf Weida Tong Russell D Wolfinger

Nat Biotechnol 2010 Aug 30;28(8):827-38. Epub 2010 Jul 30.

National Center for Toxicological Research, US Food and Drug Administration, Jefferson, Arkansas, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nbt.1665DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3315840PMC
August 2010

Development of candidate genomic markers to select breast cancer patients for dasatinib therapy.

Mol Cancer Ther 2010 May 27;9(5):1120-7. Epub 2010 Apr 27.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1535-7163.MCT-09-1117DOI Listing
May 2010

Predictors of tumor progression during neoadjuvant chemotherapy in breast cancer.

J Clin Oncol 2010 Apr 15;28(11):1821-8. Epub 2010 Mar 15.

Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2009.25.3286DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860366PMC
April 2010

Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis.

Cancer Res 2009 Nov 3;69(22):8579-84. Epub 2009 Nov 3.

Department of Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77054, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1934DOI Listing
November 2009

The bimodality index: a criterion for discovering and ranking bimodal signatures from cancer gene expression profiling data.

Cancer Inform 2009 Aug 5;7:199-216. Epub 2009 Aug 5.

Department of Bioinformatics and Computational Biology, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2730180PMC
August 2009

The HER-2 receptor and breast cancer: ten years of targeted anti-HER-2 therapy and personalized medicine.

Oncologist 2009 Apr 3;14(4):320-68. Epub 2009 Apr 3.

Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, NY 12208, USA.

View Article

Download full-text PDF

Source
http://theoncologist.alphamedpress.org/cgi/doi/10.1634/theon
Publisher Site
http://dx.doi.org/10.1634/theoncologist.2008-0230DOI Listing
April 2009

Ductal carcinoma in situ: state of the science and roadmap to advance the field.

J Clin Oncol 2009 Jan 8;27(2):279-88. Epub 2008 Dec 8.

The University of Texas M D Anderson Cancer Center, DCIS Discovery Program and Department of Surgical Oncology, 1515 Holcombe Blvd, Unit 444, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.18.3103DOI Listing
January 2009

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

Clin Cancer Res 2008 Dec;14(23):7909-16

Department of Breast Medical Oncology, Pathology, Surgical Oncology, Radiation Oncology and Experimental Therapeutics, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-08-1104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4375958PMC
December 2008

Effect of molecular disease subsets on disease-free survival in randomized adjuvant chemotherapy trials for estrogen receptor-positive breast cancer.

J Clin Oncol 2008 Oct 28;26(28):4679-83. Epub 2008 Jul 28.

Department of Breast Medical Oncology, The University of Texas M. D. Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2008.17.2544DOI Listing
October 2008

Evaluation of biological pathways involved in chemotherapy response in breast cancer.

Breast Cancer Res 2008 29;10(2):R37. Epub 2008 Apr 29.

Department of Breast Medical Oncology, The University of Texas M, D, Anderson Cancer Center, PO Box 301439, Houston, TX 77230-1439, USA.

View Article

Download full-text PDF

Source
http://breast-cancer-research.biomedcentral.com/articles/10.
Publisher Site
http://dx.doi.org/10.1186/bcr2088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2397539PMC
July 2008

Fingerprinting lymph node metastases.

Ann Surg Oncol 2008 May 14;15(5):1275-6. Epub 2008 Mar 14.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1245/s10434-008-9864-7DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2277447PMC
May 2008

Commercialized multigene predictors of clinical outcome for breast cancer.

Oncologist 2008 May;13(5):477-93

Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2007-0248DOI Listing
May 2008

HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancer.

Breast Cancer Res Treat 2008 Mar 28;108(2):183-90. Epub 2007 Apr 28.

Breast Cancer Unit, Institut Gustave Roussy, Villejuif, France.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10549-007-9594-8DOI Listing
March 2008

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer.

J Clin Oncol 2008 Mar 4;26(8):1275-81. Epub 2008 Feb 4.

Department of Breast Medical Oncology, The University of Texas M.D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030-1439, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.14.4147DOI Listing
March 2008

Prognostic value of initial clinical disease stage after achieving pathological complete response.

Oncologist 2008 Jan;13(1):6-15

Department of Breast Medical Oncology, Unit 1354, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Boulevard, Houston, Texas 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1634/theoncologist.2007-0107DOI Listing
January 2008

Triple negative breast carcinoma and the basal phenotype: from expression profiling to clinical practice.

Adv Anat Pathol 2007 Nov;14(6):419-30

Piper Breast Center, Virginia Piper Cancer Institute, Abbott Northwestern Hospital, Minneapolis, MN 55407, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAP.0b013e3181594733DOI Listing
November 2007

Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.

J Clin Oncol 2007 Oct 4;25(28):4414-22. Epub 2007 Sep 4.

Department of Pathology, Unit 85, The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030-4009, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.2007.10.6823DOI Listing
October 2007

Long-term outcomes in patients with mucinous, medullary, tubular, and invasive ductal carcinomas after lumpectomy.

Am J Surg 2007 Oct;194(4):527-31

Department of Surgical Oncology, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.amjsurg.2007.06.012DOI Listing
October 2007

Gene-expression microarrays provide new prognostic and predictive tests for breast cancer.

Pharmacogenomics 2007 Oct;8(10):1359-68

University of Texas, Department of Pathology, Anderson Cancer Center, Unit 53, 1515 Holcombe Blvd, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/14622416.8.10.1359DOI Listing
October 2007

Metastases to the breast from nonbreast solid neoplasms: presentation and determinants of survival.

Cancer 2007 Aug;110(4):731-7

Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77230-1402, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.22835DOI Listing
August 2007

Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer.

Clin Cancer Res 2007 Jul;13(14):4078-82

Department of Surgical Oncology, University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2600DOI Listing
July 2007

Standardizing slide-based assays in breast cancer: hormone receptors, HER2, and sentinel lymph nodes.

Clin Cancer Res 2007 May;13(10):2831-5

Department of Pathology and Laboratory Medicine, Albany Medical College, Albany, New York 12208, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-06-2522DOI Listing
May 2007

A pathologist's perspective on emerging genomic tests for breast cancer.

Authors:
W Fraser Symmans

Semin Oncol 2007 Apr;34(2 Suppl 3):S4-9

Department of Pathology, The University of Texas, M. D. Anderson Cancer Center, Houston, TX 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1053/j.seminoncol.2007.03.016DOI Listing
April 2007

Personalized medicine for breast cancer: moving forward and going back.

Per Med 2006 Nov;3(4):363-370

The University of Texas M.D. Anderson Cancer Center, Division of Breast Medical Oncology, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2217/17410541.3.4.363DOI Listing
November 2006